Clindamycin 300 mg capsules launch

In December, Creo Pharma launched a new strength of Clindamycin capsules. This is the first and only licensed clindamycin 300 mg approved for use in the UK.
For more information, please see the Public Assessment Report by the MHRA where the SPC and leaflet are included.

Posted by Marc on 15/01/13

Euro PLX March 2013

Creo Pharma will be attending the EuroPLX Pharma partnering event in Limassol,  in March 2012.

Please contact business development manager Marc Hopley to secure a meeting

Posted by creo_pharma on 10/01/13

CPhI Worldwide, 2012

Creo Pharma once again attended CPhI Worldwide in Madrid from the 8th to 11th October.

It was a busy but productive week and always good to catch up with the suppliers and customers, past and present.

Posted by creo_pharma on 01/10/12